H1

It's been great meeting with so many of you at #CTOEastCoast this week. Just a reminder that we're still available for live 10-minute demos of our AI-driven trial insights today. Stop by to see how we can help you quickly identify best-fit sites and investigators for your trial protocols. Come see us in Booth 9!

We're excited to be kicking things off at #CTOEastCoast today! We know the pressure is on for oncology teams to identify the right sites, investigators, and patients for your clinical trials. Let us show you how data-driven insights can accelerate startup and enrollment planning. Stop by Booth 9 for a live 10-minute demo!

From site selection and investigator identification to enrollment planning, every trial decision is only as good as the data behind it. At #CTOEastCoast, we're giving live demos to show how H1 can help oncology teams find the right sites, investigators, and patients before study startup begins. Visit us at Booth 9 to get a live ⏱️ 10-minute demo June 30–July 1. Reserve your spot now! https://hubs.la/Q04mHZx40

Oncology teams are under increasing pressure to identify the right sites, investigators, and patients, and to get it done faster than ever. Next week we’ll be at #CTOEastCoast showing how H1 helps you replace guesswork with data-driven decisions that accelerate trial startup and enrollment planning. Give us 10 minutes to show you how H1 can fit your workflow and deliver the right data to power your next trial. 📅 June 30 – July 1, 2026 📍 Visit us at Booth 9 for a live 10-minute demo.  Slots are filling up, so reserve yours today: https://hubs.la/Q04mCSF80

2028 may seem far away, but for health plans, it isn't. New regulatory requirements and public performance reporting are raising the stakes for provider directory accuracy. Many plans still rely on fragmented data and manual verification processes – and closing those gaps takes time. The plans that start building now will be best positioned when compliance requirements intensify. Our latest blog explores how leading health plans are using AI to automate and accelerate provider data verification and much more. Check it out here: https://hubs.la/Q04ms6cs0 #HealthcareAI #HealthPlans #ProviderDirectories #HealthcareCompliance

Using traditional methods of site selection, it can take hours of searching, filtering, and manual outreach to answer the question “Which sites are the right fit for this study?” And while many tools out there can help you identify sites, there’s only one that delivers comprehensive feasibility planning end-to-end. H1’s Site Network Suite brings site selection and feasibility into a single, AI-powered workflow. Our platform automatically interprets study protocols, recommends qualified sites, and manages outreach: all in one place. Come see what modern clinical trial planning looks like: https://hubs.la/Q04lSvMx0 #ClinicalTrials #AI #ClinicalResearch #HealthcareInnovation

Clinical development teams are no strangers to the fact that feasibility and site selection remain among the most significant drivers of timeline delays and budget overruns. Manual research across fragmented data sources limits any hope of speeding up the process. In this article on pharmaphorum, H1 CEO Ariel Katz shares how sponsors are significantly shortening the feasibility process with AI-driven, evidence-based technology while simultaneously providing structured, site-validated data for more confident decision-making. Read on to see how AI and connected data are reshaping clinical development: https://lnkd.in/ekUWfSFW 

Regulators are tightening requirements around provider data accuracy, access, and update cycles. In this playbook, learn how health plans are modernizing provider data infrastructure to maintain regulatory readiness. https://hubs.la/Q04lyHCG0

The air is abuzz with talk about AI in clinical trials, but according to a panel of healthcare leaders from OMNY, Deep 6 AI, H1, Medable, and Dyania Health, AI alone isn't the answer. The real question is: What data is powering it? One takeaway from the discussion stood out: as AI becomes more accessible, proprietary, structured, and validated, clinical data becomes the moat. Read the full blog post to learn why these leaders believe that data, not interfaces, will be the true competitive advantage: https://lnkd.in/eyAw6TxX #ClinicalTrials #LifeSciences #HealthcareAI #ClinicalResearch #PharmaInnovation #ClinicalOperations

Using traditional methods of site selection, it can take hours of searching, filtering, and manual outreach to answer the question “Which sites are the right fit for this study?” And while many tools out there can help you identify sites, there’s only one that delivers comprehensive feasibility planning end-to-end. H1’s Site Universe brings site selection and feasibility into a single, AI-powered workflow. Our platform automatically interprets study protocols, recommends qualified sites, and manages outreach: all in one place. Come see what modern clinical trial planning looks like: https://hubs.ly/Q04jV00t0 #ClinicalTrials #AI #ClinicalResearch #HealthcareInnovation